Skip to search.
 TSX Up 0.27% TSX Ventures Up 0.18%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
63.18 Down 0.49(0.77%) 4:00PM EDT
|After Hours : 63.20 Up 0.02 (0.03%) 7:19PM EDT
Add to Portfolio
Prev Close:63.67
Open:63.23
Bid:63.20 x 300
Ask:63.61 x 100
1y Target Est:65.80
Beta:1.09
Earnings Date:May 4 - May 8 (Est.)
Day's Range:60.68 - 64.00
52wk Range:22.25 - 77.80
Volume:2,721,010
Avg Vol (3m):3,345,050
Market Cap:7.52B
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ISISDown 0.77%7.52B
ENZUp 1.69%136.12M
GILDDown 0.42%145.54B
SRPTUp 7.61%590.33M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.82
Quarterly EPS Est (Mar-15) :-0.21
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-4.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback